Researchers at the Center for Studying Health System Change, sponsored by westhealth, publish a brief on approaches to health care price transparency and potential savings in health spending. (Transparency Brief) The theory behind price transparency is that if consumers are aware of prices, especially if they are responsible for large portions of the cost of services, they will choose lower cost providers or negotiate better rates with higher-cost ones. The brief makes a number of important points. One is that price awareness and availability is important to physicians as well as patients. Physicians usually have more to say about a course of treatment and who performs it than patients do and doctors often lack knowledge about costs of services and how much of that cost a patient will bear. Physicians tend to be conflicted about the role of cost in treatment decisions, with many feeling that it should not be a factor, but there is an increasing movement to encourage doctors to consider the effects of choices on the financial condition of the patient. Some studies have suggested that giving physicians more real-time information on the price of diagnostic tests, for example, may help limit spending. For patients, the issue is not as simple as understanding what the charge will be for a particular service or product. Patients need to know the overall cost of alternative courses of treatment and they need to understand their benefit design and what they will end up paying. Getting that information when multiple providers are typically involved in any significant disease or condition treatment is not easy. Perhaps most discouraging, even when price transparency tools are available, very, very few consumers use them and these tend to be pretty savvy health care patients already, and are unlikely to be the highest cost ones. So even if good information is presented to consumers, methods have to be found to engage them in the process and actively use the data for decision-making. The reality is most patients are far more concerned about quality and reputation of providers than cost, especially if they have a serious health issue. And quality data tends to be even more confusing to consumers than price information. The interaction of price and quality, especially in outcomes, has been defined as “value”, but the difficulty in gathering, presenting and getting consumers to act on cost and quality information makes moving them toward high-value health care difficult. And price transparency has its own unintended consequences–if provider pricing data becomes widely available to the public then providers can implicitly use their awareness of each other’s pricing to move the overall level higher. The brief estimates that advancing various price transparency initiatives would save at most $10 billion a year. While every little bit helps, this is not even 1% of US annual health spending. One thing that would really help is creating a nationwide database of all claims submitted to all payers, including self-pay, for health care services and products. This should include encounter data for non-fee-for-service payments. This would facilitate an understanding of actual payments and an analysis of overall provider practice patterns.
Price Transparency Savings
By Kevin RocheMay 21, 2014Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…